The Biotechnology Innovation Organization (BIO) and MichBio commend Governor Rick Snyder for signing critical legislation to create a pathway for the substitution of interchangeable biologic medicines, with appropriate communication to patients and physi
Sandoz, a Novartis division, announced that the European Medicines Agency (EMA) has accepted for regulatory review their marketing authorisation applications for biosimilars to AbbVie‘s Humira (adalimumab) and Janssen‘s Remicade (infliximab)...